Jeito Capital
Paris, FranceParis-based life-sciences venture capital fund founded 2018 by Rafaele Tordjman MD PhD (ex-Sofinnova Managing Partner) and dedicated to financing breakthrough biopharma innovation for patient benefit across Europe and North America. Two…Read full bio
Key facts
Recent exits
Coverage notes
2 funds tracked, 24 portfolio companies (21 active · 3 realized). Verified weekly from public filings and deal announcements.
About Jeito Capital
Jeito Capital is a French private equity firm with €534 million of assets under management as of December 2024, headquartered in Paris. Founded in 2018, the firm focuses on buyout and growth equity investments in European mid-cap businesses across healthcare, deploying capital from successive flagship funds with institutional limited partner support.
Investment thesis
Jeito Capital deploys buyout capital into European mid-cap and small-cap businesses across healthcare, targeting majority equity positions in profitable companies with clear value-creation runways. Investment focus emphasises operational improvement, selective bolt-on M&A acceleration and selective international expansion across France and selectively across Europe, with capital deployed from successive flagship funds backed by institutional limited partners.
Recent activity
Realised exits across the current platform vintages remain limited, with the portfolio in active deployment and value-creation phase. The platform tracks 2 fund vehicles, 19 active portfolio companies and 0 realised exits across the strategy's history. Detailed buyer names and multiple data available on Pro at €49/month.
Similar firms
Other private equity firms tracked on GP Intel.
See the full fund history.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.